Guanze Intelligent Medical posts FY26 H1 net loss of RMB 39.13 million; revenue falls 10.75% to RMB 28.43 million

• Guanze Intelligent Medical Information Industry reported a net loss of RMB 39.13 million, swinging from profit, on revenue of RMB 28.43 million.
• Revenue fell 11% year over year, reflecting a sharp drop in software sales to RMB 85,000 from RMB 10.7 million.
• Cost of sales climbed 43.8% to RMB 26.64 million, due to higher unit film costs, higher depreciation, and Share Award Scheme vesting.
• Research and development costs widened to RMB 23.12 million from RMB 2.27 million as the group increased investment in films and cloud solutions.
• Management said mobile DR equipment and electronic endoscopes under development are expected to obtain sales approval in Q4 2026 to Q1 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guanze Intelligent Medical Information Industry Holding Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12309830), on August 31, 2026, and is solely responsible for the information contained therein.